Evidence map›Paper›PMID 30866960›Full record

ArticleJournal of nanobiotechnology2019

Uptake and distribution of carboxylated quantum dots in human mesenchymal stem cells: cell growing density matters.

Gabrielis Kundrotas, Vitalijus Karabanovas, Marijus Pleckaitis, Marina Juraleviciute, Simona Steponkiene, Zivile Gudleviciene, Ricardas Rotomskis

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Virus-Mimicking Polymer Nanoparticles Targeting CD169ACS applied materials & interfaces · 2022
    Article
  10. Review
  11. Review
  12. Bone Morphogenetic Protein-2 Conjugated to Quantum DotNanomaterials (Basel, Switzerland) · 2020
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gabrielis KundrotasBiobank, National Cancer Institute, Baublio Str. 3b, 08406, Vilnius, Lithuania.ORCID http://orcid.org/0000-0002-1222-6467
Vitalijus KarabanovasBiomedical Physics Laboratory, National Cancer Institute, Baublio Str. 3b, 08406, Vilnius, Lithuania.ORCID http://orcid.org/0000-0002-5029-8840
Marijus PleckaitisBiomedical Physics Laboratory, National Cancer Institute, Baublio Str. 3b, 08406, Vilnius, Lithuania.
Marina JuraleviciuteBiomedical Physics Laboratory, National Cancer Institute, Baublio Str. 3b, 08406, Vilnius, Lithuania.
Simona SteponkieneBiomedical Physics Laboratory, National Cancer Institute, Baublio Str. 3b, 08406, Vilnius, Lithuania.
Zivile GudlevicieneBiobank, National Cancer Institute, Baublio Str. 3b, 08406, Vilnius, Lithuania.
Ricardas RotomskisBiomedical Physics Laboratory, National Cancer Institute, Baublio Str. 3b, 08406, Vilnius, Lithuania. ricardas.rotomskis@nvi.lt.
National Cancer Institute · LTVilnius Gediminas Technical University · LTVilnius University · LT

Funding

the European Union Structural Funds & the Ministry of Education and Science of the Republic of Lithuania VP1-3.1-SMM-01-V-01-001the European Union Structural Funds & the Ministry of Education and Science of the Republic of Lithuania VP1-3.1-SMM-10-V-02-027the Norwegian Financial Mechanism and the Republic of Lithuania LT0036
6 · The paper itself

Abstract

backgroundHuman mesenchymal stem cells (MSCs) have drawn much attention in the field of regenerative medicine for their immunomodulatory and anti-inflammatory effects. MSCs possess specific tumor-oriented migration and incorporation highlighting the potential for MSCs to be used as an ideal carrier for anticancer agents. Bone marrow is the main source of MSCs for clinical applications. MSCs tracking in vivo is a critical component of the safety and efficacy evaluation of therapeutic cell products; therefore, cells must be labeled with contrast agents to enable visualization of the MSCs migration in vivo. Due to their unique properties, quantum dots (QDs) are emerging as optimal tools in long-term MSC optical imaging applications. The aim of this study was to investigate the uptake dynamics, cytotoxity, subcellular and extracellular distribution of non-targeted carboxylated quantum dots in human bone marrow MSCs at different cell growing densities.

resultsQDs had no negative impact on MSC viability throughout the experiment and accumulated in all observed cells efficiently; however, in some MSCs QDs induced formation of lipid droplets. At low cell growing densities QDs distribute within MSCs cytoplasm already after 1 h of incubation reaching saturation after 6 h. After 24 h QDs localize mainly in the perinuclear region of the cells in endosomes. Interestingly, in more confluent culture QDs localize mostly outside MSCs. QDs abundantly mark MSC long filopodia-like structures attaching neighboring cells. At high cell density cultivation, we for the first time demonstrated that carboxylated QDs localize in human bone marrow MSC extracellular matrix. Moreover, we observed that average photoluminescence lifetime of QDs distributed in extracellular matrix are longer than lifetimes of QDs entrapped in endocytic vesicles; thus, for the first time showing the possibility to identify and distinguish localization of QDs in various extracellular and intracellular structures using fluorescence-lifetime imaging microscopy without additional staining assays.

conclusionCarboxylated QDs can be used as nonspecific and effective dye for staining of human bone marrow MSCs and their specific extracellular structures. These results are promising in fundamental stem cell biology as well as in cellular therapy, anticancer drug delivery and tissue engineering.

Indexed as

Biological TransportCarboxylic AcidsCell MovementCell SurvivalExtracellular MatrixFluorescent DyesHumansMesenchymal Stem CellsOptical ImagingQuantum DotsStaining and LabelingTime FactorsCarboxylic AcidsFluorescent DyesExtracellular matrixFilopodia-like structuresFluorescence imagingFluorescence-lifetime imaging microscopyLabelingMesenchymal stem cellsQuantum dots

Identifiers

PMID30866960
PMCPMC6417192
OpenAlexW2937792746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.